Immunohistochemical techniques were employed to examine the distribution of RNA-binding proteins A2 and B1 in the rat forebrain. Intense A2 and B1 immunolabeling were observed in the nucleoplasm of the neurons in the cerebral cortices, hippocampal formation, olfactory regions, caudate-putamen as well as the supraoptic nucleus of hypothalamus. In contrast, within the bed nucleus of the stria terminalis, as well as the medial and lateral habenular nucleus of thalamus, immunoreactivity for both proteins was weak. Within the globus pallidus and thalamic nucleus immunoreactivity for A2 was hardly detectable despite of intense B1 immunolabeling, while within the endopiriform nucleus and lateral and basolateral nucleus of amygdala intensity of B1 immunolabeling was relatively weak compared to A2. Our study suggests that the distribution of A2 and B1 are not constant throughout the forebrain and this diversity may re¯ect the post-transcriptional regulation of cellspeci®c gene expression of neuronal cells. NeuroReport
INTRODUCTION
It is well known that the heterogeneous nuclear ribonucleoprotein (hnRNP) proteins directly bind to pre-mRNA forming a large multiprotein±RNA complex and have important roles in the splicing and transport of mRNAs [1, 2] . The hnRNP A2 and B1 proteins are among the most abundant of the $20 major hnRNP proteins in the human nucleus [1] . A2 and B1 are produced by alternative splicing from a single copy gene [3] , and differ from each other only by a 12 amino acid insertion in the N-terminal of B1 [4] . We produced two monoclonal antibodies against these two proteins (i.e., DP3 and 2B2), and demonstrated tissuespeci®c variations in the amounts of these two proteins [5, 6] . Although A2 and B1 proteins are abundantly expressed in the brain, the detailed distribution of these proteins in the brain is still unknown. In this study, immunohistochemical techniques were employed in order to examine the detailed distribution of A2 and B1 proteins in the rat forebrain.
MATERIALS AND METHODS
Six male Sprague±Dawley rats weighing $250 g were anesthetized with 360 mg/kg chloral hydrate and were killed by transcardial perfusion with 4% paraformaldehyde in 100 mM phosphate buffer. Following 24 h post-®xation the brains were placed in 30% sucrose for 3 days and then sectioned at 40 ìm in the coronal plane and processed for immunocytochemistry as described [7] . Tissue sections were immunocytochemically labeled using the avidin± biotin-immunolabeled procedure using DP3 and 2B2, both of which are raised in mice; DP3 represents A2 while 2B2 represents B1 [6] . The primary antibodies were diluted 1/ 500 for DP3 and 1/2000 for 2B2 in Tris±saline containing 1% goat serum and 0.25% Triton X-100. Aminoethylcarbamazole was used as a coloring reagent. The ®nal dilutions of the antibodies were determined following experiments in which a number of dilutions were tested (i.e. dilution curve). Sections were processed together in order to control for any variability in the immunocytochemical procedure. The adjacent section was stained for Nissl substance to delineate the cytoarchitecture described by Kruger et al. [8] and Paxinos [9] .
RESULTS
Throughout the brain immunoreactivity for both DP3 and 2B2 was localized in the nucleoplasm of neurons and ependymal cells and widely distributed even though the labeling intensity varied depending on regions and cell types. Within the cerebral cortex, hippocampus, olfactory regions and caudate-putamen, as well as the supraoptic nucleus of the hypothalamus, we observed intensely DP3-labeled neurons (Fig. 1a±c) . Within the cerebral cortex, DP3 immunolabeling was prominent in layers II and III, as well as in a large neuron in layer V, while in the other layers immunoreactivity was weak. A lobar difference in labeling pattern was not remarkable. Within the olfactory cortex, hippocampus, caudate-putamen and the supraoptic nucleus, the labeling intensity was variable depending on neurons, although a number of neurons were intensely labeled (Fig. 1b,c) . In contrast, within the globus pallidus, bed nucleus of the stria terminalis and throughout the thalamic regions, immunoreactivity for DP3 was hardly detectable (Fig. 1c,d ). In the other regions, such as the septal nucleus, nucleus accumbens, diagonal band, substantia inominata, amygdala complex and the hypothalamus, neurons demonstrated a moderate intensity of DP3 immunolabeling.
2B2-immunolabeled neurons were also distributed throughout the brain. An intense immunoreactivity for 2B2 was observed in the regions in which the intense DP3 labeling was present. In these regions, a staining pattern of 2B2 was almost comparable to that of DP3, although within the caudate-putamen a number of lightly labeled neurons were observed in addition to intensely labeled neurons (Fig.  2a) . However, an intense 2B2 immunolabeling was more widely distributed compared to DP3. For example, in the globus pallidus (Fig. 2a) , most thalamic regions (Fig. 2b) , the diagonal band, substantia inominata and the ventromedial nucleus of the hypothalamus, the majority of neurons were intensely 2B2 positive. In contrast to the ventromedial nucleus, within the dorsomedial nucleus a number of neurons demonstrated a weak immunoreactivity for 2B2, thus providing us with a clear demarcation between these two regions (Fig. 2c) . In addition, within the bed nucleus of the stria terminalis, lateral habenular nucleus, lateral and basolateral nucleus of the amygdala, as well as the endopiriform nucleus, intensity of 2B2 immunolabeling was weak. Within the medial habenular nucleus the majority of neurons appeared unlabeled while some neurons demonstrated an intense immunoreactivity for 2B2 (Fig. 2d) . Both DP3 and 2B2 immunolabeling were barely detected in glial elements. The labeling intensities of DP3 and 2B2 are classi®ed into three categories: undetectable or weak (À), moderate () and intense ( ) according to the previous report [6] , and the data are summarized in Table 1 .
DISCUSSION
Since DP3 and 2B2 immunoreactivity represent A2 and B1 expression, respectively [6] , the present data demonstrate the comprehensive study of the expression patterns of hnRNP A2 and B1 proteins in the forebrain. The results of this study suggest that expression for A2 and B1 was varied in different regions. In some regions such as the cerebral cortex, hippocampus, olfactory regions, caudateputamen, as well as the supraoptic nucleus, immunoreactivity for both A2 and B1 was robust. In contrast, in the Fig. 1 . Photomicrographs showing immunoreactivity for DP3. Within the parietal cortex, intense immunoreactivity for DP3 was observed in layers II and III, as well as a large neuron in layer V (arrow) while in the other layers immunoreactivity was weak (a). In the hippocampus (b) and caudateputamen (CP; c) a number of neurons were intensely labeled although the labeling intensity was varied depending on neurons. In contrast, within the globus pallidus (GP; c) as well as the mediodorsal nucleus of the thalamus, immunoreactivity for DP3 was hardly detectable (d). Bar 100 ìm (a±c); 50 ìm (d).
bed nucleus of the stria terminalis, as well as in the medial and lateral habenular nucleus, immunoreactivity for the two proteins was weak. The amounts of major hnRNP proteins may, in part, re¯ect the activities of transcription and RNA processing. Thus, in interpreting our observations, it is possible to speculate that in regions demonstrating an intense labeling for both A2 and B1 the transcriptional activity is high, while in regions with a weak labeling for both of them the activity is low. However, studies of functional activities in the rat brain by measurements of glucose utilization [10, 11] and cytochrome oxidase [12] argue against this speculation. According to these studies the regions with a highly functional activity consist of the cerebral cortex, thalamus and lateral habenular nucleus, while the regions with a low activity consist of the hippocampus, amygdala, globus pallidus, medial habenular nucleus and hypothalamus [10±12], although a speci®c functional activity remains to be determined in these regions. Therefore, the intensity of A2 and B1 labeling in neurons is probably relevant to factors other than transcriptional activity, such as post-transcriptional activity.
Within the different regions we observed clear discrepancies of the expression between A2 and B1. Within the globus pallidus and most thalamic nuclei, A2 labeling was more modest than B1. In contrast, within the endopiriform nucleus, lateral and basolateral nucleus of the amygdala, as well as the dorsomedial nucleus of hypothalamus, A2 labeling was relatively robust compared to B1. Within the caudate-putamen the number of intensely B1-positive neurons was much smaller than intensely A2-positive neurons. These results lead us to an idea that the speci®c roles of A2 and B1 are not equivalent in the brain. In previous studies with various tissues we demonstrated that the amount of A2 and B1 proteins varied signi®cantly, depending on the cell type, and suggested that cell type-speci®c expression of hnRNP proteins re¯ects the post-transcriptional regulation of cell-speci®c gene expression [5, 6] . Taken together with the fact that neurons are a highly differentiated cell and their various functions are regulated at a post-transcriptional level as well as a transcriptional level, it is plausible to consider that varieties in the expression of A2 and B1 proteins in the brain re¯ect the post-transcriptional regulation of neuron-speci®c gene expression, such as alternative splicing, metabolism and transport of RNAs.
Recent studies demonstrate that A2 protein binds myelin-basic protein in glial cells [13, 14] and A2 play a role for transport of myelin-basic protein to the distal ends of the process [14] . In this study, however, neither A2 nor B1 immunoreactivity was observed in the glial cells. It is reasonable to suppose that the amount of these proteins was insuf®cient to be immunohistochemically detected in glial cells. Improvements in sensitivity of immunohistochemical methods using tyramide signal ampli®cation (NEN Life Science Pro. Inc, Boston, MA) enable us to detect immunoreactivity in glial elements.
CONCLUSION
Our results suggest that the expression of A2 and B1 are not constant throughout the brain and this diversity may re¯ect the post-transcriptional regulation of cell-speci®c gene expression of neurons.
